Well we are already nearly 2 weeks into the 26 week countdown until the unblinding of the results (approx last week of Oct/first of Nov). Has there been a mention or indication of how long it will take for reporting from LCT management to review the results and release to the public, or has anyone with experience in this field got any idea?
Our next big tell tale of results will be in August when the Phase I/IIa results are updated on their 81 week progress (Living Insights Feb17).
What I don't understand is on slide 15 of the CEO Presentation, it shows the patients' results after 81 weeks in the graph. Am I interpreting something incorrectly?
Cheers
Well we are already nearly 2 weeks into the 26 week countdown...
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $7.007K | 1.008M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 2864983 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2187552 | 7 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |